Skip to main content
    O

    OUTLOOK THERAPEUTICS INC (OTLK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.40
    -0.02 (-4.12%)

    Market Cap: $100.54M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OUTLOOK THERAPEUTICS INC (OTLK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to OUTLOOK THERAPEUTICS INC are Compass Therapeutics (CMPX), OKYO Pharma (OKYO) and Pmv Pharmaceuticals (PMVP). By market cap, OUTLOOK THERAPEUTICS INC ranks 7th of the 13 companies on this page; Invivyd (IVVD) is the largest at $171.58M.

    Peer Comparison

    OTLK's revenue growth of -99.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    OKYO Pharma Limited (OKYO)$70.85MN/AN/A0.0%N/A0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Voyager Therapeutics Inc (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Coya Therapeutics, Inc. Common Stock (COYA)$73.42MN/A15.0x0.0%N/A-93.4%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    OnKure Therapeutics, Inc. (OKUR)$108.33MN/AN/A0.0%N/A0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Peer median$99.27MN/A4.0x0.0%-260.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to OUTLOOK THERAPEUTICS INC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors
    OKYO Pharma Limited (OKYO)
    OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye...
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Voyager Therapeutics Inc (VYGR)
    Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases.
    VYGR competitors
    Coya Therapeutics, Inc. Common Stock (COYA)
    Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs).
    COYA competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors
    OnKure Therapeutics, Inc. (OKUR)
    OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer.
    OKUR competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors

    Frequently Asked Questions About OTLK

    Who are OUTLOOK THERAPEUTICS INC's main competitors?

    The companies most similar to OUTLOOK THERAPEUTICS INC include Compass Therapeutics (CMPX), OKYO Pharma (OKYO), Pmv Pharmaceuticals (PMVP), NeOnc Technologies Holdings, Inc. Common Stock (NTHI) and Immunic (IMUX), listed from the closest match.

    Who is OUTLOOK THERAPEUTICS INC's biggest competitor?

    Invivyd (IVVD) is the largest of the similar companies at $171.58M; Compass Therapeutics (CMPX) is the closest match by business profile, size, sector and industry.

    How does OTLK stock compare with its competitors?

    OTLK's net margin is 0.0% against a peer median of 0.0%.

    Which of OUTLOOK THERAPEUTICS INC's competitors pays a higher dividend?

    OUTLOOK THERAPEUTICS INC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is OUTLOOK THERAPEUTICS INC bigger than its competitors?

    No. OUTLOOK THERAPEUTICS INC is 7th by market cap among the 13 companies on this page; the largest is Invivyd (IVVD) at $171.58M.